Genetics Inst., LLC v.Novartis Vaccines & Diagnostics, Inc.

The district court dismissed plaintiff's suit (35 U.S.C. 291) alleging interference with patent claims relating to truncated forms of an essential blood-clotting protein. The Federal Circuit affirmed, after first holding that the expiration of one of the patents following the district court’s final decision did not strip it of jurisdiction over the appeal. The district court properly determined that there was no interference in fact.